Patents
Patents for C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
10/2007
10/04/2007WO2007112451A2 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007US20070231300 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents
10/04/2007US20070229732 Chiral compounds
09/2007
09/26/2007CN101044133A Trioxane production method
09/20/2007US20070219363 Crown ether complex for use in delivery of biopolymers to animal cells
09/19/2007CN100338054C 手性化合物 Chiral compound
09/18/2007US7271210 Stabilized ester compositions and their use in film-forming compositions
09/12/2007EP1527064B1 Preparation of lactic acid derivatives and their use
09/12/2007CN101033220A Method of preparing dihyperoxide with two rings
09/05/2007EP1828286A1 Process for preparing trioxepane composition and use thereof in crosslinking polymers
09/04/2007US7265229 Method for synthesizing macrosphelides
09/04/2007US7265152 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
08/2007
08/28/2007US7262236 Dibenzylidenesorbitol derivatives made by condensation, acetalization, and cyclization of benzaldehyde derivative and mono-, di-, or tri-acetal substituted alditol; nucleating, gelling, or clarifying agents; thickeners; plastic and/or polypropylene additive
08/23/2007US20070197805 preparation of alkoxycarbonylmethoxy cyclopentanes which are useful intermediates in the preparation of pharmaceutically active triazolo[4,5-d]pyrimidine cyclopentanes
08/16/2007US20070191475 Antimalarial agents; multidrug-resistant malaria; e.g. [3-(1-Phenyl-vinyl)-1,2,5-trioxa-spiro[5.5]undec-9-ylidene]-acetic acid ethyl ester
08/14/2007US7256286 Bryostatins exhibit potent activity against a broad range of human cancer cell lines
08/08/2007EP1814537A2 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
08/07/2007US7252784 Cyclic ketone peroxide formulations
08/02/2007WO2007068776B1 Antitumour compounds
07/2007
07/25/2007EP1581207A4 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
07/25/2007CN101006073A Method for the separation by distillation of pure trioxane
07/17/2007US7244854 Method of synthesizing trioxymethylene from formaldehyde by the catalytic action of an ionic liquid
07/12/2007WO2007077479A1 Spiro-1,2,4-trioxanes as antimalarial agents
07/12/2007WO2006113432A3 Compounds, compositions and methods
07/11/2007EP1805162A1 Trioxane production method wherein a side aqueous flow is deducted at a first distillation stage
07/05/2007US20070155972 Method for separating trioxane from a mixture containing trioxane, formaldehyde and water
06/2007
06/28/2007WO2007072983A1 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure
06/28/2007WO2006091885A3 A registry method and control system for dea schedule ii-v medicines
06/26/2007US7235663 E.g., 2,6-Diethyl-4,4-dimethoxy-2,3,6-trimethyl-1-(1-(4-oxir-anylmethoxy-phenyl) -ethoxy)-piperidine or 7,9-Diethyl-2,6, 7,9-tetramethyl-8-(1-(4-oxiranylmethoxy-phenyl)-ethoxy)-1,4-dioxa-8-aza -spiro(4.5)decane; anionic polymerization
06/21/2007WO2007068776A1 Antitumour compounds
06/21/2007CA2633543A1 Antitumour compounds
06/14/2007US20070135649 Cyclizing formaldehyde to produce trioxane using an imidazolium or pyridinium cationic catalyst with p-tolyl benzene sulfonate, trifluoromethyl sulfonate, or hydrogen sulfate anionic catalyst
06/13/2007CN1978438A Method for synthesizing tripoly aldehyde by ionic liquid catalysis of aldehyde
06/12/2007US7230123 Ureido or carbamate derivatives of crown ethers and of silicon usable for preparing supports intended for the separation by chromatography of metal cations and of organic molecules comprising amine functional groups
05/2007
05/29/2007US7223450 Chiral compounds
05/24/2007US20070117989 Methanesulfonic acid [7-(4-nitrophenyl)-(5H,9H)-6,8-dioxabenzocyclohepten-2-yl]methyl ester; chemical intermediates
05/10/2007WO2007051762A1 Process for producing trioxane and at least one comonomer
05/10/2007CA2627080A1 Process for producing trioxane and at least one comonomer
05/09/2007EP1781634A1 Method for the separation by distillation of pure trioxane
05/03/2007DE102005051974A1 Preparing trioxane and comonomer, useful for preparing trioxane based (co)polymer, comprises converting formaldehyde and co-monomer educt to trioxane and co-monomer, and distillating the obtained reaction mixtures
05/01/2007US7211693 Preparation of lactic acid derivatives and their use
04/2007
04/25/2007CN1951902A Preparation process of lactic acid oligomer
04/25/2007CN1312157C Halogenated dihydroartemisine, preparation and use thereof
04/18/2007EP1773804A2 Sls for tooling applications
04/17/2007US7205401 Separation of such enantiomers with non-chromatographic resin bed separations of three separation stages or less; efficiency; chiral purity
04/11/2007EP1771435A2 Modulators of central nervous system neurotransmitters
04/11/2007EP1123094B1 Therapeutic compositions (ii)
03/2007
03/28/2007CN1307182C Preparation of bromo-dihydroartemisine
03/21/2007CN1931856A Crown ether condensed thiosemicarbazide as anion recognizing receptor and its prepn and application
03/07/2007CN1303076C Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same
03/01/2007WO2007023187A1 Method for production of polyoxymethylene homo- or co-polymers
03/01/2007CA2620161A1 Method for production of polyoxymethylene homo- or co-polymers
02/2007
02/21/2007CN1918142A Method for separating trioxane from a trioxane/formaldehyde/water mixture by means of pressure change rectification
02/15/2007WO2007017479A1 Integrated method for producing trioxane from formaldehyde
02/15/2007WO2007017410A1 Integrated method for the production of trioxane from formaldehyde
02/15/2007US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
02/15/2007US20070037464 Isolation, formulation, and shaping of macrocyclic oligoesters
02/15/2007DE102005037294A1 Integriertes Verfahren zur Herstellung von Trioxan aus Formaldehyd Integrated process for preparing trioxane from formaldehyde
02/15/2007DE102005037293A1 Integriertes Verfahren zur Herstellung von Trioxan aus Formaldehyd Integrated process for preparing trioxane from formaldehyde
02/15/2007DE102005036544A1 Integriertes Verfahren zur Herstellung von Trioxan aus Formaldehyd Integrated process for preparing trioxane from formaldehyde
02/15/2007CA2623573A1 Integrated method for the production of trioxane from formaldehyde
02/15/2007CA2617479A1 Integrated method for producing trioxane from formaldehyde
02/14/2007EP1509512B1 Method for producing pure trioxane
02/08/2007WO2007014853A1 Integrated process for preparing trioxane from formaldehyde
02/08/2007CA2623572A1 Integrated process for preparing trioxane from formaldehyde
02/07/2007EP1748767A1 Diarylalkanes as potent inhibitors of binuclear enzymes
02/06/2007US7173141 Phenyl substitited lactone; prepared in optically pure form from meso-fiydrobenzoin; chemical intermediate for alpha -hydroxy acids and 1,2-diols using catalytic hydrogenation
01/2007
01/25/2007WO2007009388A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof
01/24/2007CN1900081A Water soluble artemisine derivative and its preparing method, medicinal composition and use
01/17/2007CN1897999A Method for separating trioxane from a mixture containing trioxane, formaldehyde and water
01/17/2007CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
01/17/2007CN1295231C Bromo-dihydroartemisine
01/10/2007EP1538148B1 Chiral sensor
01/10/2007EP1203616B1 Chiral lead catalyst and method of asymmetric aldol reaction
12/2006
12/27/2006EP1343745B1 Process for removing methanol from formaldehyde-containing solutions
12/21/2006WO2006134121A1 Method for producing polyoxymethylenes from purified monomers
12/19/2006US7151152 Crosslinking plural polymers through mechanical bonding with a rotaxane structure consisting of a shaft and rings; recycling by decrosslinking the crosslinked body having a disulfide bond in the presence of thiols
12/14/2006WO2006060142A3 Nucleophile assisting leaving groups
12/14/2006WO2005108479A3 Acetal-based compositions
12/14/2006US20060281931 for oil in water emulsions
12/14/2006US20060281881 Crystallizing cyclic ketone peroxides, one or more dialkyl peroxides, and, optionally, one or more conventional phlegmatisers; in polymerization and (co)polymer modification; polymerization initiator
12/13/2006CN1289602C Species modification in macrocyclic polyester oligomers and compositions prepared thereby
12/13/2006CN1289453C Process for removing methanol from formaldehyde-containing solutions
11/2006
11/16/2006DE10228857B4 Tetraetherlipide mit kleinen Kopfgruppen, deren Herstellung und Verwendung Tetraether lipids with small head groups, their preparation and use
11/02/2006US20060247449 Method for purifying glycolide
11/02/2006EP1716153A2 Methods, compositions, and apparatuses for forming macrocyclic compounds
10/2006
10/26/2006WO2006036941A3 Specific kinase inhibitors
10/18/2006CN1849290A Intermediate product composed of mixture of organic carbonate and carbamate and producing art thereof
10/12/2006US20060229352 asenapine synthesis, a schizophrenia drug
09/2006
09/28/2006WO2006101073A1 Anti-cancer agent and bacterium capable of producing novel compound prunustatin
09/21/2006US20060211764 Cell activator, process for producing cell activator and apparatus therefor
09/14/2006WO2006095771A1 Complex compound and mri probe made of same
09/14/2006WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
09/14/2006US20060205816 Phenyl substitited lactone; prepared in optically pure form from meso-fiydrobenzoin; chemical intermediate for alpha -hydroxy acids and 1,2-diols using catalytic hydrogenation
09/13/2006EP1699776A1 Method for separating trioxane from a trioxane/formaldehyde/water mixture by means of pressure change rectification
09/13/2006EP1699537A1 Method for separating trioxane from a mixture containing trioxane, formaldehyde and water
09/13/2006EP1414813B1 1,2,4-trioxolane antimalarials
09/12/2006CA2195537C Cyclic ketone peroxide formulations
09/06/2006EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16